Emergent BioSolutions Inc. Business Finance Contracts & Agreements

120 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Subscription Agreement, dated August 30, 2024, between Emergent BioSolutions Inc. and the Subscribing Entities
Subscription Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2024
Form of Warrant (included in Exhibit 10.2)
Warrant Agreements
Emergent BioSolutions Inc.
Biotechnology
DE
2024
Credit Agreement, dated as of August 30, 2024, by and among Emergent BioSolutions Inc., the lenders from time to time party thereto and OHA Agency LLC, as administrative agent
Credit Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2024
First Supplemental Indenture, dated as of August 30, 2024, by and among Emergent BioSolutions Inc., the subsidiary guarantors party thereto and U.S. Bank Trust Company, National...
Indenture Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2024
Modification No. 29, effective June 16, 2022, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 28, effective April 14, 2022, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 27, effective March 31, 2022, to the Solicitation/Contract/Order for Commercial Items (the CDC BioThrax Procurement Contract), effective December 8, 2016, from...
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 32, effective November 1, 2021, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 31, effective October 20, 2021, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 8, effective
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 4, effective
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 3, effective
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 6, effective, November 1, 2021 to the ACAM2000 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 5, effective, September 29, 2021 to the ACAM2000 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 4, effective, July 13, 2021 to the ACAM2000 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 1
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 26, effective November 1, 2021, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Agreement to Terminate Class A Stockholders Registration Rights Agreement, dated December 9, 2021 by and among Emergent BioSolutions Inc., Intervac, L.L.C. and BioVac, L.L.C
Registration Rights Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 25, effective September 29, 2021, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 24, effective February 2, 2021, to the Solicitation/Contract/Order for Commercial Items, effective December 8, 2016, from the Centers for Disease Control and...
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 11, effective September 30, 2021, to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 2, effective August 29, 2018, to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 1, effective March 16 2017, to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 1, effective
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 28, effective May 27, 2021, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 10, effective June 10, 2021 to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 9, effective April 21, 2021, to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 8, effective March 22, 2021, to the BARDA AV7909 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 6, effective March 24, 2021, to Task Order 75A50120F33007
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 5, effective February 22, 2021, to Task Order 75A50120F33007
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 26, effective November 2, 2020 to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 2, effective November 17, 2020, to Task Order 75A50120F33008
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 3, effective October 7, 2020, to Task Order 75A50120F33007
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 2, effective September 18, 2020, to Task Order 75A50120F33007
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 2, effective, October 28, 2020 to the ACAM 2000 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 23, effective September 30, 2020, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 2
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 2
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Global Form of Restricted Stock Unit Award Agreement
Stock Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 1, effective August 24, 2020, to
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2020